Fei-Xiang Lin
Impact in
-
- Mesenchymal stem cell research
Papers in
-
- Bone Metabolism and Diseases 3
- TGF-β signaling in diseases 2
- Connexins and lens biology 2
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
-
- Spinal Cord Injury Research 4
- Co-authors
- Bo-Jui Chang (7 shared papers)Shi‐xin Du (6 shared papers)Xuedong Li (6 shared papers)Da Xie (5 shared papers)Dezhong Liu (5 shared papers)Guoyong Yu (4 shared papers)Qihao Zhang (4 shared papers)Peng Xie (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Molecular Neurobiology (2 papers)Experimental Neurology (1 paper)Cellular Physiology and Biochemistry (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- China
In The Last Decade
Fei-Xiang Lin
14 papers receiving 281 citations
Peers
Comparison fields: 5 of 71
- Orthopedics and Sports Medicine 20
- Genetics 24
- Pathology and Forensic Medicine 39
- Molecular Biology 144
- Geriatrics and Gerontology 8
Countries citing papers authored by Fei-Xiang Lin
This map shows the geographic impact of Fei-Xiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei-Xiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei-Xiang Lin more than expected).
Fields of papers citing papers by Fei-Xiang Lin
This network shows the impact of papers produced by Fei-Xiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei-Xiang Lin. The network helps show where Fei-Xiang Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei-Xiang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 41 | |
| 2 | 2017 | 40 | |
| 3 | 2018 | 37 | |
| 4 | 2019 | 34 | |
| 5 | 2016 | 30 | |
| 6 | 2021 | 23 | |
| 7 | Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway. | 2016 | 22 |
| 8 | 2024 | 16 | |
| 9 | 2023 | 16 | |
| 10 | All-trans-retinoic acid activates SDF-1/CXCR4/ROCK2 signaling pathway to inhibit chondrogenesis. | 2017 | 9 |
| 11 | 2018 | 6 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2021 | 1 | |
| 15 | 2024 | 0 | |
| 16 | 2025 | 0 |
About Fei-Xiang Lin
Fei-Xiang Lin is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Oncology and Surgery, having authored 16 papers that have together received 282 indexed citations. Recurring topics across this work include Spinal Cord Injury Research (4 papers), Nerve injury and regeneration (3 papers), Bone Metabolism and Diseases (3 papers), TGF-β signaling in diseases (2 papers), Connexins and lens biology (2 papers), Bone health and treatments (2 papers), RNA Interference and Gene Delivery (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Orthopedics and Sports Medicine (20 citations), Genetics (24 citations), Pathology and Forensic Medicine (39 citations), Molecular Biology (144 citations) and Geriatrics and Gerontology (8 citations). Fei-Xiang Lin has collaborated with scholars based in China. Frequent co-authors include Bo-Jui Chang, Shi‐xin Du, Xuedong Li, Da Xie, Dezhong Liu, Guoyong Yu, Qihao Zhang, Peng Xie, Wei He and Gang Zheng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Molecular Neurobiology, Experimental Neurology, Cellular Physiology and Biochemistry and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.